ARCHIVES

FDA News: Zydelig approved in three B-cell blood cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

Program Announcement listed.

July 25, 2003

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Revised Guidelines For Core, Exploratory Grants Available

March 5, 1976

NIH Seeking Nominations for Review Committees

February 23, 1979

ASCO Updates Guideline On Antiemetics

June 30, 2006